OT
Oricell Therapeutics
China · Biotech · Healthtech
Develops next-generation cell therapies for oncology and immunology
Funding history
2 rounds · 2 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Pre-IPO | $110M | Beijing Medical and Health Care Industry Investment Fund — Role not disclosedElikon Investment — Role not disclosedE-Town Capital — Role not disclosedLuxin Venture Capital — Role not disclosedNGS Super — Role not disclosedQiming Venture Partners — Role not disclosedTalon Capital — Role not disclosedVivo Capital — Role not disclosed | |
| Series C1 | $70M | Beijing Medical and Health Care Industry Investment Fund — Role not disclosedElikon Venture — Role not disclosedE-Town Capital — Role not disclosedleading global healthcare fund — Role not disclosedNGS Super (NGS) — Role not disclosedQiming Venture Partners — Role not disclosedsovereign wealth fund — Role not disclosedTalon Capital — Role not disclosed |